Again Life Italia Announces Partnership with Tanner Pharma Group
CHARLOTTE, N.C., May 27, 2021 — Again Life Italia S.r.l. (“ALI”), a pharmaceutical biotechnology company headquartered in Italy, and TannerLAC UK Limited (“TannerLAC”), a wholly owned subsidiary of Tanner Pharma Group and company leader in the Latin American market, announced today the signing of a business partnership agreement for Latin America.
With a presence in more than 60 countries around the world, ALI is dedicated above all to supporting cancer patients undergoing chemo and radiation therapy. Similarly, TannerLAC is focused on supporting patients by providing access to medications during the care path.
Carolina Cortez, Executive Vice President of TannerLAC, commented, “We are very excited about the opportunity to bring innovative ideas and products to help those patients in Latin America who suffer from the consequences of therapies, and to improve their quality of life.”
Antonella Sardei added, “Our partnership with TannerLAC is strategic to promote the products and the philosophy of Again Life Italia in Latin American countries and is in line with the company’s mission in supporting patients, especially those affected by side effects related to anticancer treatments, giving them the respect due to those who suffer.”
The objective of the two companies is to bring ALI’s technological innovation to the market in countries such as Argentina, Brazil, Chile, Colombia, Ecuador, Mexico, and Peru through the expertise and professionalism of one of the most important groups in Latin America such as TannerLAC.
This collaboration represents an important step in the international development of ALI, and TannerLAC values the opportunity to partner with ALI and bring innovative biotechnology solutions to Latin America.
About Again Life Italia:
Again Life Italia S.r.l. is an Italian company, specialized in biotechnology and focused on research, development and marketing. Again Life Italia is present in the international market through collaborations in partnership with other international companies operating in specific countries. For years, Again Life Italia has dedicated particular attention to supportive therapies for the treatment of side effects caused by anticancer therapies such as radio- and chemotherapy. ALI is now an international player in supporting cancer patients, covering 92% of the side effects of therapies that have a significant impact on patients’ daily lives. Thanks to Again Life Italia, the symptoms caused by anticancer therapies can now be effectively controlled with a wide range of patented and tested products.
ALI’s research has made it possible to identify a number of compounds capable of playing an important role in improving the quality of life of patients. ALI’s research is covered by internationally registered patents, constituting a cultural heritage made available for people who suffer.
About Tanner Pharma Group:
For over 18 years, Tanner Pharma Group has partnered with companies to provide turn-key solutions to increase access to medicines and other medical technology around the world. By partnering with Tanner Pharma Group, companies are able to focus on their primary markets while ensuring that patients and clinicians in international markets can receive their products through a strictly controlled channel. Tanner Pharma Group is headquartered in the United States with offices in the United Kingdom, Switzerland, Ireland and Brazil. Tanner Pharma Group has a global reach and provides international commercialization and patient access through licensing, managed access programs, global access programs and clinical trial services. For more information, please visit www.tannerpharma.com.